← Eichor
Study identifier: NCT05323383 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Effects and Mechanisms of Brief Mindfulness Meditation and Hypnosis for Pain

Condition: Pain · Chronic Pain  ·  Sponsor: The University of Queensland

PhaseNA
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to determine the effects and mechanisms of 1 x 20-min training in mindfulness meditation and self-hypnosis relative to an inert control. Participants will be randomly assigned to condition. The dual primary outcomes will be pre- to post-training changes in current pain intensity and pain unpleasantness. The active treatments are hypothesized to produce greater reductions in pain outcomes than the control. It is also hypothesized that change in mindfulness will be a mediator specific to mindfulness meditation, while change in affect and decentering will be mediators of the hypnosis condition. Moderators of response will also be explored.

This description comes directly from the study's public registry record.

Talk to the study team

Melissa Day, Ph.D.  ·  +61 7 3365 6421  ·  m.day@uq.edu.au

Always discuss trial participation with your own doctor first.

Locations (1)

The University of QueenslandBrisbane, Queensland, AustraliaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05323383